Regulatory Genome Development Ltd (RegGenome), a commercial spin-out from the University of Cambridge, has today announced the completion of a $6 million seed funding round.
The round is led by Evolution Equity Partners, with participation from AlbionVC, Cambridge Enterprise, and Mastercard. Richard Seewald, Managing Partner of Evolution Equity Partners, will join RegGenome’s board of directors.
RegGenome’s vision is to transform the way the world consumes regulatory information. The company provides structured machine-readable regulatory content that is dynamic, granular, and interoperable—all powered by AI-based textual information extraction techniques. This enables regulatory authorities to increase accessibility and dissemination of regulatory information and empowers organisations to deepen their regulatory intelligence and digitise their compliance and risk management processes.
If you are a journalist and need further information, please contact our Press and Media Manager.